Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Brent Kreider"'
Autor:
Siqing Fu, Daniel Karp, Maura Gillison, Anjali Raina, Brent Kreider, David Tung, Mary Varterasian, Khashayarsha Khazaie
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/ba48607310d4483681b7e8a606847402
Publikováno v:
RSF: The Russell Sage Foundation Journal of the Social Sciences, Vol 4, Iss 2, Pp 113-130 (2018)
Although the central objective of the Supplemental Nutrition Assistance Program (SNAP) is to reduce food insecurity in the United States, the majority of SNAP households are food insecure. Higher benefits may lead these households to food security. T
Externí odkaz:
https://doaj.org/article/94656be4f61747f9acc7cc021ce4b588
Autor:
Andrew DJ. Pearson, Carl Allen, Jason Fangusaro, Caroline Hutter, Olaf Witt, Susan Weiner, Gregory Reaman, Mark Russo, Pratiti Bandopadhayay, Sama Ahsan, Amy Barone, Elly Barry, Teresa de Rojas, Michael Fisher, Elizabeth Fox, Julia Glade Bender, Lia Gore, Darren Hargrave, Doug Hawkins, Brent Kreider, Abraham J. Langseth, Giovanni Lesa, Franca Ligas, Marcelo Marotti, Lynley V. Marshall, Kahina Nasri, Koen Norga, Karsten Nysom, Alberto Pappo, Gianluca Rossato, Nicole Scobie, Malcolm Smith, Elliot Stieglitz, Brenda Weigel, Amy Weinstein, Ruth Viana, Dominik Karres, Gilles Vassal
Publikováno v:
European Journal of Cancer. 177:120-142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e51cb81f4e064a01a1e1d2c5bc7d4f56
https://doi.org/10.1016/j.ejca.2022.09.036
https://doi.org/10.1016/j.ejca.2022.09.036
Autor:
Patrick M Grierson, Benjamin Tan, Katrina S Pedersen, Haeseong Park, Rama Suresh, Manik A Amin, Nikolaos A Trikalinos, Deborah Knoerzer, Brent Kreider, Anupama Reddy, Jingxia Liu, Channing J Der, Andrea Wang-Gillam, Kian-Huat Lim
Publikováno v:
The Oncologist. 28:e115-e123
Background Ulixertinib is a novel oral ERK inhibitor that has shown promising single-agent activity in a phase I clinical trial that included patients with RAS-mutant cancers. Methods We conducted a phase Ib trial combining ulixertinib with gemcitabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cdb0f1e6bc92be438d6c2e05bedd2da
https://doi.org/10.1093/oncolo/oyac237
https://doi.org/10.1093/oncolo/oyac237
Autor:
Mrinal M. Gounder, Khashayarsha Khazaie, Mary Varterasian, Brent Kreider, David Tung, Alexey A. Leontovich, Saurabh Saha, Linping Zhang, Ronald L. Korn, Jennifer L. Salstrom, Maria Miller, Amanda Collins, Gary DeCrescenzo, Ernest Trevino, Alice Weissfeld, Stephen B. Solomon, Jean Torrisi, Anjali Raina, Divya Sakamuri, Steven Y. Huang, Mark Klang, Daniel D. Karp, Sarina A. Piha-Paul, David S. Hong, Tyler Masters, Thorunn Helgason, Dale R. Shepard, Andrea Wang-Gillam, Ravi Murthy, Sanjay Goel, Abdulmohammad Pezeshki, Halle Huihong Zhang, Filip Janku
Supplementary Figure 1. Of 16 patients (7 with and 9 without germination) with available data, 11 (69%) had a decrease in tumor density (-4% to -476%). The most robust decreases in density were observed in patients with germination. Supplementary Fig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c81284b48a4d230d3f1da9bd671c963
https://doi.org/10.1158/1078-0432.22478556
https://doi.org/10.1158/1078-0432.22478556
Autor:
Mrinal M. Gounder, Khashayarsha Khazaie, Mary Varterasian, Brent Kreider, David Tung, Alexey A. Leontovich, Saurabh Saha, Linping Zhang, Ronald L. Korn, Jennifer L. Salstrom, Maria Miller, Amanda Collins, Gary DeCrescenzo, Ernest Trevino, Alice Weissfeld, Stephen B. Solomon, Jean Torrisi, Anjali Raina, Divya Sakamuri, Steven Y. Huang, Mark Klang, Daniel D. Karp, Sarina A. Piha-Paul, David S. Hong, Tyler Masters, Thorunn Helgason, Dale R. Shepard, Andrea Wang-Gillam, Ravi Murthy, Sanjay Goel, Abdulmohammad Pezeshki, Halle Huihong Zhang, Filip Janku
Purpose:Intratumorally injected Clostridium novyi-NT (nontoxic; lacking the alpha toxin), an attenuated strain of C. novyi, replicates within hypoxic tumor regions resulting in tumor-confined cell lysis and inflammatory response in animals, which war
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee8c35e7baa12ec727650c1b68bd0ce
https://doi.org/10.1158/1078-0432.c.6529983.v1
https://doi.org/10.1158/1078-0432.c.6529983.v1
Autor:
Mrinal M. Gounder, Khashayarsha Khazaie, Mary Varterasian, Brent Kreider, David Tung, Alexey A. Leontovich, Saurabh Saha, Linping Zhang, Ronald L. Korn, Jennifer L. Salstrom, Maria Miller, Amanda Collins, Gary DeCrescenzo, Ernest Trevino, Alice Weissfeld, Stephen B. Solomon, Jean Torrisi, Anjali Raina, Divya Sakamuri, Steven Y. Huang, Mark Klang, Daniel D. Karp, Sarina A. Piha-Paul, David S. Hong, Tyler Masters, Thorunn Helgason, Dale R. Shepard, Andrea Wang-Gillam, Ravi Murthy, Sanjay Goel, Abdulmohammad Pezeshki, Halle Huihong Zhang, Filip Janku
Supplementary Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::354c39856fd9064a50cef4f72fd2f95a
https://doi.org/10.1158/1078-0432.22478550
https://doi.org/10.1158/1078-0432.22478550
Publikováno v:
Applied Economic Perspectives and Policy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::922bbd6a83a4bab077cd2cb90218f3e6
https://doi.org/10.1002/aepp.13327
https://doi.org/10.1002/aepp.13327
Autor:
Deborah Knoerzer, Anupama Reddy, Jessica A. Box, Anna Groover, Brent Kreider, Martin Teresk, Caroline M. Emery
Publikováno v:
Cancer Research. 83:2692-2692
Ulixertinib (BVD-523) is a first-in-class and best-in-class small molecule inhibitor of ERK1/2 currently being investigated in several oncology clinical trials, both as a single agent and in combination with other therapeutics. Ulixertinib has demons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1819c9fdd6803b9ae6f265a527509922
https://doi.org/10.1158/1538-7445.am2023-2692
https://doi.org/10.1158/1538-7445.am2023-2692
Autor:
Andrea Wang-Gillam, Ernest Trevino, Sarina Anne Piha-Paul, Halle H. Zhang, Khashayarsha Khazaie, Amanda Collins, Tyler Masters, Mark Klang, Thorunn Helgason, Daniel D. Karp, Sanjay Goel, David Tung, Ronald L. Korn, Alexey A. Leontovich, Brent Kreider, Filip Janku, Mary Varterasian, Saurabh Saha, Divya Sakamuri, Maria Miller, David S. Hong, Anjali Raina, Jennifer L. Salstrom, Jean Torrisi, Decrescenzo Gary A, Alice S. Weissfeld, Linping Zhang, Dale R. Shepard, Abdul Mohammad Pezeshki, Stephen B. Solomon, Mrinal M. Gounder, Steven Y. Huang, Ravi Murthy
Publikováno v:
Clinical Cancer Research. 27:96-106
Purpose: Intratumorally injected Clostridium novyi-NT (nontoxic; lacking the alpha toxin), an attenuated strain of C. novyi, replicates within hypoxic tumor regions resulting in tumor-confined cell lysis and inflammatory response in animals, which wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::022f02290a6facded3246c3101a97367
https://doi.org/10.1158/1078-0432.ccr-20-2065
https://doi.org/10.1158/1078-0432.ccr-20-2065